BIFARI, FRANCESCO
BIFARI, FRANCESCO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Reply to the letter comment of Su Boon Yong MD, PhD and colleagues to: Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE− 2 study
2025 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Tumor-associated macrophages enhance tumor innervation and spinal cord repair
2024 S. Dolci, L. Mannino, A. Campanelli, E. Rossi, E. Bottani, F. Ciarpella, I. Karkossa, E. Setten, B. Savino, G. Pruonto, N. Piazza, S. Gianoli, A. Amenta, G. Busetto, A. Pezzotta, M. Di Chio, A. Castagna, N. Martinelli, I. Barone, F. Boschi, A. Doherty, M. Teresa Scupoli, C. Cavallini, G. Malpeli, Z. Malik, L. Sagripanti, V. Silani, P. Cristofori, E. Scanziani, M. Sandri, A. Pistocchi, P. Bossolasco, M. Endrizzi, K. Schubert, G. Francesco Fumagalli, M. Locati, F. Bifari, I. Decimo
In vitro assessment of the Neural Regenerative properties of Regenerative Macrophages (REMaST®)
2024 G. Pruonto, L. Sagripanti, I. Barone, A. Amenta, S. Dolci, E. Rossi, L. Mannino, F. Ciarpella, N. Piazza, B. Savino, P. Bossolasco, G. Fumagalli, M. Locati, I. Decimo, F. Bifari
Improved glycemic and weight control with Dulaglutide addition in SGLT2 inhibitor treated obese type 2 diabetic patients at high cardiovascular risk in a real-world setting. The AWARE-2 study
2024 C. Berra, R. Manfrini, F. Bifari, E. Cipponeri, R. Ghelardi, L. Centofanti, U. Mortola, E. Lunati, L. Bucciarelli, V. Cimino, F. Folli
Modulation of cellular metabolism as therapy for progressive multiple sclerosis
2024 R. Esposito, A. Amenta, Z. Malik, M. Miotto, A. Finardi, R. Furlan, G. Martano, F. Bifari
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population. CA.ME.LI.A study 7 year follow-up
2024 M. Bignotto, E. Bianco, L. Centofanti, A. Russo, M. Dei Cas, P. Zermiani, C. Morano, F. Samartin, E. Bertolini, F. Bifari, C. Berra, M. Zuin, R. Paroni, P.M. Battezzati, F. Folli
Meninges as an overlooked pharmacological target for Globoid Cell Leukodystrophy
2023 A. Amenta, Z. Malik, C. Quaranta, G. Pruonto, A. Ricca, F. Cascino, S. Dolci, F. Ciarpella, M. Riva, I. Decimo, G. Angela, F. Bifari
Embryonic, Organ and Other Tissue Specific Stem Cells: Generation of 3d human brain organoids from adult human meningeal neural stem/progenitor cells
2023 Z. Malik, A. Amenta, F. Ciarpella, R.G. Zamfir, G. Pruonto, M. Di Chio, S. Dolci, A. Campanelli, L. Pizzamiglio, C. Cambria, F. Antonucci, M. Riva, I. Decimo, F. Bifari
Identification and characterization of the Neural Stem/Progenitor Cell population in the Adult Human Brain Meninges
2023 A. Amenta, Z. Malik, G. Pruonto, M. Di Chio, A. Campanelli, S. Dolci, F. Ciarpella, C. Cambria, F. Antonucci, M. Riva, I. Decimo, F. Bifari
AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus
2023 C. Berra, R. Manfrini, M. Mirani, L. Bucciarelli, A.S. Zakaria, S. Piccini, R. Ghelardi, M.E. Lunati, S. Rodovalho, F. Bifari, P. Fiorina, F. Folli
Consistency and Variation in Doublecortin and Ki67 Antigen Detection in the Brain Tissue of Different Mammals, including Humans
2023 M. Ghibaudi, A. Amenta, M. Agosti, M. Riva, J. Graïc, F. Bifari, L. Bonfanti
Development of quality controls to assess the potency of Human Regenerative Macrophages (REMaST®) for clinical use
2023 G. Pruonto, L. Sagripanti, I. Barone, A. Amenta, S. Dolci, E. Rossi, L. Mannino, F. Ciarpella, N. Piazza, S. Gianoli, B. Savino, P. Bossolasco, G. Francesco Fumagalli, M. Locati, I. Decimo, F. Bifari
Esmethadone-HCl (REL-1017): a promising rapid antidepressant
2023 M. Fava, S.M. Stahl, S. De Martin, A. Mattarei, E. Bettini, S. Comai, A. Alimonti, F. Bifari, L. Pani, F. Folli, C. Guidetti, A. Furlan, J. Sgrignani, P. Locatelli, A. Cavalli, C. O'Gorman, S. Traversa, C.E. Inturrisi, M. Pappagallo, P.L. Manfredi
Therapeutic induction of energy metabolism reduces neural tissue damage and increases microglia activation in severe spinal cord injury
2022 S. Dolci, L. Mannino, E. Bottani, A. Campanelli, M. Di Chio, S. Zorzin, G. D'Arrigo, A. Amenta, A. Segala, G. Paglia, V. Denti, G. Fumagalli, E. Nisoli, A. Valerio, C. Verderio, G. Martano, F. Bifari, I. Decimo
Pharmacological Comparative Characterization of REL-1017 (Esmethadone-HCl) and Other NMDAR Channel Blockers in Human Heterodimeric N-Methyl-D-Aspartate Receptors
2022 E. Bettini, S.M. Stahl, S. De Martin, A. Mattarei, J. Sgrignani, C. Carignani, S. Nola, P. Locatelli, M. Pappagallo, C.E. Inturrisi, F. Bifari, A. Cavalli, A. Alimonti, L. Pani, M. Fava, S. Traversa, F. Folli, P.L. Manfredi
Isolation and in-vitro Characterization of the Adult Neural Stem/Progenitor Cells from the Human Brain Meninges
2022 A. Amenta, Z. Malik, G. Pruonto, M. Di Chio, A. Campanelli, S. Dolci, F. Ciarpella, L. Pizzamiglio, C.M. Cambria, F. Antonucci, M. Riva, I. Decimo, F. Bifari
REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats
2022 F. Bifari, M. Pappagallo, M. Bleavins, S. Traversa, F. Folli, P.L. Manfredi
REL-1017 (esmethadone; D-methadone) does not cause reinforcing effect, physical dependence and withdrawal signs in Sprague Dawley rats
2022 J. Henningfield, D. Gauvin, F. Bifari, R. Fant, M. Shram, A. Buchhalter, J. Ashworth, R. Lanier, M. Pappagallo, C. Inturrisi, F. Folli, S. Traversa, P.L. Manfredi
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants: A Report of 2 Cases
2022 C. Guidetti, G. Serra, L. Pani, M. Pappagallo, G. Maglio, M. Trasolini, S. De Martin, A. Mattarei, F. Bifari, F. Folli, P.L. Manfredi, M. Fava
The N-Methyl-D-Aspartate Receptor Blocker REL-1017 (Esmethadone) Reduces Calcium Influx Induced by Glutamate, Quinolinic Acid, and Gentamicin
2022 E. Bettini, S. De Martin, A. Mattarei, M. Pappagallo, S.M. Stahl, F. Bifari, C.E. Inturrisi, F. Folli, S. Traversa, P.L. Manfredi